Single nucleotide polymorphisms in C-reactive protein (CRP) predict response to adjunctive celecoxib treatment of resistant bipolar depression
Background: Affective illness has been associated with a proinflammatory state, and it is generally accepted that the immune system plays a key role in the pathophysiology of mood disorders. Since inflammatory biomarkers are elevated in bipolar disorder, anti-inflammatory combination therapies may e...
Main Authors: | Angelos Halaris, Daniel Hain, Rebecca Law, Lisa Brown, David Lewis, Maria Filip |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | Brain, Behavior, & Immunity - Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266635462300039X |
Similar Items
-
Modulation of the inflammatory response exerts beneficial effects on anger in treatment-resistant bipolar depression
by: A Halaris, et al.
Published: (2023-07-01) -
Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX‐2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis
by: Toshinori Shirata, et al.
Published: (2023-06-01) -
Diminution of Heart Rate Variability in Bipolar Depression
by: Brandon Hage, et al.
Published: (2017-12-01) -
Association between single nucleotide polymorphism of BMAL1 and bipolar disorder
by: MIN Wenjiao, et al.
Published: (2022-11-01) -
Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: a placebo-controlled, double-blind, randomised study
by: Mona Kargar, et al.
Published: (2014-02-01)